Can newly developed, rapid immunochromatographic antigen detection tests be reliably used for the laboratory diagnosis of influenza virus infections?

Journal of Clinical Microbiology

Volumn 53, Issue 6, 2015, Pages 1790-1796

  Dunn, James J ^a   Ginocchio, Christine C ^b,c  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b BIOMÉRIEUX   (France)

^c DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN DETECTION; ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; HEALTH CARE COST; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; IMMUNOASSAY; IMMUNOASSAY ANALYZER; INFLUENZA; INFLUENZA A RAPID TEST; INFLUENZA VIRUS A; INFLUENZA VIRUS B; INTERMETHOD COMPARISON; LIMIT OF DETECTION; NUCLEIC ACID AMPLIFICATION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; QUALITATIVE ANALYSIS; RAPID INFLUENZA DIAGNOSTIC TEST; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS CULTURE; VIRUS DETECTION; VIRUS STRAIN; ADOLESCENT; ADULT; CHILD; INFANT; INFLUENZA A VIRUS; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; PROCEDURES; REPRODUCIBILITY; STANDARDS; VIROLOGY; YOUNG ADULT;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

VIRUS ANTIGEN;

ADOLESCENT; ADULT; ANTIGENS, VIRAL; CHILD; CHILD, PRESCHOOL; HUMANS; IMMUNOCHROMATOGRAPHY; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS; INFLUENZA, HUMAN; MIDDLE AGED; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 84929379015     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02739-14     Document Type: Article

References (34)

1. Welch DF, Ginocchio CC. 2010. Role of rapid immunochromatographic antigen testing in diagnosis of influenza A virus 2009 H1N1 infection. J Clin Microbiol 48:22-25. http://dx.doi.org/10.1128/JCM.02268-09.
2. Centers for Disease Control and Prevention. 2009. Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) virus- United States. MMWR Morb Mortal Wkly Rep 58:826-829.
3. Ginocchio CC, Zhang F, Manji R, Arora S, Bornfreund M, Falk L, Lotlikar M, Kowerska M, Becker G, Korologos D, de Geronimo M, Crawford JM. 2009. Evaluation of multiple test methods for the detection of the novel 2009 influenza A (H1N1) during the New York City outbreak. J Clin Virol 45:191-195. http://dx.doi.org/10.1016/j.jcv.2009.06.005.
4. US Food and Drug Administration. 24 February 2015. Premarket notification 510(k). Food and Drug Administration, Silver Spring, MD. http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/HowtoMarketYourDevice/PremarketSubmissions/PremarketNotification510k/default.htm.
5. Beck E, Fan J, Hendrickson K, Kumar S, Shively R, Kramp W, Villanueva J, Jernigan D, Kilmov A, Chen LM, Donis R, Williams T, Pirkle J, Barr J. 2012. Evaluation of 11 commercially available rapid influenza diagnostic tests-United States, 2011-2012. MMWR Morb Mortal Wkly Rep 61:873-876.
6. Chan KH, Chan KM, Ho YL, Lam YP, Tong HL, Poon LL, Cowling BJ, Peiris JS. 2012. Quantitative analysis of four rapid antigen assays for detection of pandemic H1N1 2009 compared with seasonal H1N1 and H3N2 influenza A viruses on nasopharyngeal aspirates from patients with influenza. J Virol Methods 186:184-188. http://dx.doi.org/10.1016/j .jviromet.2012.09.001.
7. Yang JR, Lo J, Ho YL, Wu HS, Liu MT. 2011. Pandemic H1N1 and seasonal H3N2 influenza infection in the human population show different distributions of viral loads, which substantially affect the performance of rapid influenza tests. Virus Res 155:163-167. http://dx.doi.org/10.1016/j.virusres.2010.09.015.
8. Quidel Corp. 2014. Sophia influenza A+B FIA, package insert 1219103EN01. Quidel Corp, San Diego, CA.
9. Becton, Dickinson and Company. 2012. BD Veritor System for rapid detection of flu A+B 8087667(03). Becton, Dickinson and Company, Sparks, MD.
10. Gao F, Loring C, Laviolette M, Bolton D, Daly ER, Bean C. 2012. Detection of 2009 pandemic influenza A(H1N1) virus infection in different age groups by using rapid influenza diagnostic tests. Influenza Other Respir Viruses 6: e30-e34. http://dx.doi.org/10.1111/j.1750-2659.2011.00313.x.
11. Lee CK, Cho CH, Woo MK, Nyeck AE, Lim CS, Kim WJ. 2012. Evaluation of Sofia fluorescent immunoassay analyzer for influenza A/B virus. J Clin Virol 55:239-243. http://dx.doi.org/10.1016/j.jcv.2012.07 .008.
12. Rath B, Tief F, Obermeier P, Tuerk E, Karsch K, Muehlhans S, Adamou E, Duwe S, Schweiger. 2012. Early detection of influenza A and B infection in infants and children using conventional and fluorescence-based rapid testing. J Clin Virol 55:329-333. http://dx.doi.org/10.1016/j.jcv .2012.08.002.
13. Leonardi GP, Wilson AM, Zuretti AR. 2013. Comparison of conventional lateral-flow assays and a new fluorescent immunoassay to detect influenza viruses. J Virol Methods 189:379-382. http://dx.doi.org/10.1016/j.jviromet.2013.02.008.
14. Dunn J, Obukewe J, Baun T, Rogers J, Patel T, Snow L. 2014. Prompt detection of influenza A and B viruses using the BD Veritor System Flu A+B, Quidel Sofia Influenza A+B FIA, and Alere BinaxNOW® influenza A&B compared to real-time reverse transcription-polymerase chain reaction (RT-PCR). Diagn Microbiol Infect Dis 79:10-13. http://dx.doi.org/10.1016/j.diagmicrobio.2014.01.018.
15. Hassan F, Nguyen A, Bell JJ, Selvarangan R. 2014. Comparison of the BD Veritor System for Flu A+B with the Alere BinaxNOW influenza A&B card for detection of influenza A and B viruses in respiratory specimens from pediatric patients. J Clin Microbiol 52:906-910. http://dx.doi.org/10.1128/JCM.02484-13.
16. Nam MH, Jang JW, Lee JH, Cho CH, Lim CS, Kim WJ. 2014. Clinical performance evaluation of the BD Veritor System Flu A+B assay. J Virol Methods 204:86-90. http://dx.doi.org/10.1016/j.jviromet.2014.04.009.
17. Balish A, Garten R, Klimov A, Villanueva J. 2013. Analytical detection of influenza A(H3N2)v and other A variant viruses from the USA by rapid influenza diagnostic tests. Influenza Other Respir Viruses 7:491-496. http://dx.doi.org/10.1111/irv.12017.
18. Code of Federal Regulations. 2001. Title 21. Food and drugs. Chapter I. Food and Drug Administration. Subchapter H. Medical devices. Part 866. Immunology and microbiology devices. Section 866.3330. Influenza virus serological reagents. 21 CFR 866.3330. http://www.accessdata.fda.gov/SCRIPTs/cdrh/cfdocs/cfcfr/cfrsearch.cfm?fr=866.3330.
19. Petrozzino JJ, Smith C, Atkinson MJ. 2010. Rapid diagnostic testing for seasonal influenza: an evidence-based review and comparison with unaided clinical diagnosis. J Emerg Med 39:476-490. http://dx.doi.org/10.1016/j.jemermed.2009.11.031.
20. Centers for Disease Control and Prevention. 2014. Guidance for clinicians on the use of RT-PCR and other molecular assays for diagnosis of influenza virus infection. Centers for Disease Control and Protection, Atlanta, GA. http://www.cdc.gov/flu/professionals/diagnosis/molecular -assays.htm.
21. Kumar S, Henrickson KJ. 2012. Update on influenza diagnostics: lessons from the novel H1N1 influenza A pandemic. Clin Microbiol Rev 25:344-361. http://dx.doi.org/10.1128/CMR.05016-11.
22. Cheng VCC, To KKW, Tse H, Hung IFN, Yuen K-Y. 2012. Two years after pandemic influenza A/2009/H1 N1: what have we learned? Clin Microbiol Rev 25:223-263. http://dx.doi.org/10.1128/CMR.05012-11.
23. Rodgers BB, Shankar P, Jerris RC, Kotzbauer D, Anderson EJ, Watson JR, O'Brian LA, Uwindatwa F, McNamara K, Bost JE. 25 August 2014. Impact of a rapid respiratory panel test on patient outcomes. Arch Pathol Lab Med http://dx.doi.org/10.5858/arpa.2014-0257-OA.
24. Yassi A, McGill M, Holton D, Nicolle L. 1993. Morbidity, cost and role of health care worker transmission in an influenza outbreak in a tertiary care hospital. Can J Infect Dis 4:52-56.
25. Eibach D, Casalegno JS, Bouscambert M, Benet T, Regis C, Comte B, Kim BA, Vanhems P, Lina B. 2014. Routes of transmission during a nosocomial influenza A(H3N2) outbreak among geriatric patients and healthcare workers. J Hosp Infect 86:188-193. http://dx.doi.org/10.1016/j.jhin.2013.11.009.
26. Hansen S, Stamm-Balderjan S, Zuschneid I, Behnke M, Ruden H, Vonberg RP, Gastmeier P. 2007. Closure of medical departments during nosocomial outbreaks: data from a systematic analysis of the literature. J Hosp Infect 65:348-353. http://dx.doi.org/10.1016/j.jhin.2006.12.018.
27. Pollara CP, Piccinelli G, Rossi G, Perandin F, Corbellini S, De Tomasi D, Bonfanti C. 2013. Nosocomial outbreak of the pandemic influenza A (H1N1) 2009 in critical hematologic patients during seasonal influenza 2010-2011: detection of oseltamivir resistant variant viruses. BMC Infect Dis 13:127-133. http://dx.doi.org/10.1186/1471-2334-13-127.
28. Gooskens J, Jonges M, Claas ECJ, Meijer A, van den Broek PJ, Kroes AC. 2009. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A (H1N1). JAMA 301:1042-1046. http://dx.doi.org/10.1001/jama.2009.297.
29. Feng L, Li Z, Zhao S, Nair H, Lai S, Xu W, Li M, Wu J, Ren L, Liu W, Yuan Z, Chen YU, Wang X, Zhao Z, Zhang H, Li F, Ye X, Li S, Feikin D, Yu H, Yang W. 2014. Viral etiologies of hospitalized acute lower respiratory infection patients in China, 209-2013. PLoS One 9(6): e99419. http://dx.doi.org/10.1371/journal.pone.0099419.
30. Zhang D, He Z, Xu L, Zhu X, Wu J, Wen W, Zheng Y, Deng Y, Chen J, Hu Y, Li M. 2014. Epidemiology characteristics of respiratory viruses found in children and adults with respiratory tract infections in southern China. Int J Infect Dis 25:159-164. http://dx.doi.org/10.1016/j.ijid.2014 .02.019.
31. Ginocchio CC, St George K. 2009. Likelihood that an unsubtypeable influenza A result in the Luminex xTAG respiratory virus panel is indicative of novel A/H1N1 (swine-like) influenza. J Clin Microbiol 47:2347-2348. http://dx.doi.org/10.1128/JCM.01027-09.
32. Centers for Disease Control and Prevention. 8 January 2015. Influenza antiviral drug resistance. Centers for Disease Control and Prevention, Atlanta, GA. http://www.cdc.gov/flu/about/qa/antiviralresistance.htm.
33. Cheng PKC, Wong KKY, Mak GC, Wong AH, Ng AYY, Chow SYK, Lam RKH, Lau CS, Ng KC, Lim W. 2010. Performance of laboratory diagnostics for the detection of influenza A (H1N1)v virus as correlated with the time after symptom onset and viral load. J Clin Virol 47:182-185. http://dx.doi.org/10.1016/j.jcv.2009.11.022.
34. Williams LO, Kupka NJ, Schmaltz SP, Barrett S, Uyeki TM, Jerigan DB. 2014. Rapid influenza diagnostic use and antiviral prescriptions in outpatient settings pre- and post-2009 H1N1 pandemic. J Clin Virol 60:27-33. http://dx.doi.org/10.1016/j.jcv.2014.01.016.